JP2007522162A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522162A5
JP2007522162A5 JP2006552520A JP2006552520A JP2007522162A5 JP 2007522162 A5 JP2007522162 A5 JP 2007522162A5 JP 2006552520 A JP2006552520 A JP 2006552520A JP 2006552520 A JP2006552520 A JP 2006552520A JP 2007522162 A5 JP2007522162 A5 JP 2007522162A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
alkylene
hydrogen
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006552520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522162A (ja
JP4916317B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/001232 external-priority patent/WO2005077361A1/de
Publication of JP2007522162A publication Critical patent/JP2007522162A/ja
Publication of JP2007522162A5 publication Critical patent/JP2007522162A5/ja
Application granted granted Critical
Publication of JP4916317B2 publication Critical patent/JP4916317B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006552520A 2004-02-14 2005-02-08 新規持続作用性β−2−アゴニスト及び薬剤としてのその使用 Expired - Fee Related JP4916317B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04003354 2004-02-14
EP04003354.0 2004-02-14
PCT/EP2005/001232 WO2005077361A1 (de) 2004-02-14 2005-02-08 Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
JP2007522162A JP2007522162A (ja) 2007-08-09
JP2007522162A5 true JP2007522162A5 (OSRAM) 2008-03-27
JP4916317B2 JP4916317B2 (ja) 2012-04-11

Family

ID=34854551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552520A Expired - Fee Related JP4916317B2 (ja) 2004-02-14 2005-02-08 新規持続作用性β−2−アゴニスト及び薬剤としてのその使用

Country Status (7)

Country Link
EP (1) EP1720546B1 (OSRAM)
JP (1) JP4916317B2 (OSRAM)
AT (1) ATE479433T1 (OSRAM)
CA (1) CA2552871A1 (OSRAM)
DE (1) DE502005010170D1 (OSRAM)
ES (1) ES2349470T3 (OSRAM)
WO (1) WO2005077361A1 (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
EP1924553A1 (en) 2005-08-08 2008-05-28 Argenta Discovery Limited Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
SI2013211T1 (sl) 2006-04-21 2012-07-31 Novartis Ag Purinski derivati za uporabo kot agonisti receptorja adenozina A A
WO2008017638A1 (de) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP5584138B2 (ja) 2008-01-11 2014-09-03 ノバルティス アーゲー キナーゼ阻害剤としてのピリミジン類
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
JP5555255B2 (ja) 2008-12-30 2014-07-23 プルマゲン セラピューティクス(インフラメーション)リミテッド 呼吸器疾患の治療のためのスルホンアミド化合物
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
GEP20156285B (en) 2011-02-25 2015-05-11 Aierem Elelsi Compounds and compositions as trk inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
EP1305300A1 (de) * 2000-04-27 2003-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Similar Documents

Publication Publication Date Title
JP2007522162A5 (OSRAM)
US12180198B2 (en) Ribocil C antibiotics effective for Gram-negative pathogens
JP2010523522A5 (OSRAM)
JP2006526590A5 (OSRAM)
JP2009084270A5 (OSRAM)
JP2019510787A5 (OSRAM)
JP2014037426A5 (OSRAM)
JP2009532417A5 (OSRAM)
JP2004516314A5 (OSRAM)
JP2013508279A5 (OSRAM)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
ES2437346T3 (es) Procedimiento para la producción de derivado de diamina
JP2012522759A5 (OSRAM)
JP2008509187A5 (OSRAM)
JP6087367B2 (ja) 三環式化合物、それらを含む組成物およびそれらの使用
TWI455938B (zh) 碳酸啶衍生物及其醫藥組成物
JP2014503480A5 (OSRAM)
JP2013532668A5 (OSRAM)
JP2015510942A5 (OSRAM)
JP2011500621A5 (OSRAM)
JP2013519653A5 (OSRAM)
JP2014505017A5 (OSRAM)
CA2541781A1 (en) 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses
JP2013518036A5 (OSRAM)
TW200901986A (en) New combination